Research & Development
Pathology & AI
Emerging Technology: Page 2
Foundation Medicine wins FDA approval for companion diagnostic to prostate cancer treatment
FoundationOne CDx analyzes more than 300 cancer-related genes for genomic alterations. The ability of the product to test for alterations and select gene rearrangements and genomic signatures has led to its approval as a CDx for multiple products.
August 16, 2023
Researchers engineer bacterial biosensor that can detect tumor DNA
The technique, dubbed Cellular Assay for Targeted CRISPR-discriminated Horizontal gene transfer and known by the acronym CATCH, was designed to identify specific DNA sequences and mutations outside of cells.
August 14, 2023
Quest Diagnostics teams up with Envision Science on prostate cancer biomarkers
The test aims to improve the accuracy of grading biopsies for prostate cancer, which is one of the most prevalent and deadly cancers affecting men.
July 27, 2023
Physicians advocate for ‘careful’ use of osteoporosis bone turnover marker testing
Knowing the rate of bone matrix removal or deposition can help physicians understand if a patient is at risk of fractures or is responding to treatment.
July 24, 2023
Vector Laboratories buys Quanta Bio for polyethylene glycol technology
Single molecular weight, discrete-length PEG chains such as Quanta’s dPEG products can simplify peptide analysis compared to other products that contain a range of PEG chain lengths and molecular weights.
July 24, 2023
Quest launches biomarker test to improve grading of prostate cancer biopsies
Building on the Australian research and working with Envision Sciences, the Australian diagnostics company that owns the biomarker intellectual property, Quest’s subspecialty pathology business, AmeriPath, has developed a tissue-based test.
July 17, 2023
Thermo Fisher rolls out software to help clinical labs cut time to result
The software, Diomni Enterprise, is designed to address the problems that “antiquated systems” cause for clinical labs and kit manufacturers.
July 14, 2023
DiamiR Biosciences partners with JADBio on diagnostic tests, validation for biomarker panels
Under the deal, DiamiR will apply the capabilities of JADBio’s Automated Machine Learning (AutoML) bioinformatics platform and services to its own microRNA platform.
July 12, 2023
TScan teams with Tempus to develop companion diagnostic for cancer cell therapy
The biotech firm TScan has identified Tempus as a company that can help it select the right treatments for patients. Tempus is the developer of xT CDx, a companion diagnostic that the FDA approved earlier this year.
July 11, 2023
Precision diagnostics finds its “caviar moment”
When assembled into networks, the capsules formed the basis of discrete “smart skins” for bodily sensing, capable of recording muscular, breathing, pulse, and blood pressure measurements in real time with ultra-high precision, the academics found.
July 10, 2023
Epic Systems achieves milestone with exchange of structured genomic data through its EHR systems
The landmark moment occurred in April 2023 between two unnamed health organizations when they exchanged clinical information for a patient they cared for in common, using Epic’s Care Everywhere health information exchange functionality.
July 5, 2023
Lab-on-a-chip tech enables fast, cheap tuberculosis detection in study
The St George’s and QuantuMDx collaborators identified dielectrophoresis as a way to improve testing for TB. Using the technique, the researchers isolated the bacteria that cause TB from the rest of the content of sputum samples.
July 3, 2023
Page 2 of 49